Adult toxicology in critical care: Part I: General approach to the intoxicated patient

Chest

Volumn 123, Issue 2, 2003, Pages 577-592

  Mokhlesi, Babak ^a   Leiken, Jerrold B ^b   Murray, Patrick ^c   Corbridge, Thomas C ^d  

^a Jr Hospital of Cook County   (United States)

^b Evanston NW Healthcare OMEGA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Critical care; ICU; Poisoning; Toxicology; Toxidromes

Indexed keywords

4 METHYLPYRAZOLE; ACETYLCYSTEINE; ACTIVATED CARBON; ALCOHOL; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIDOTE; ATROPINE; CARDIOVASCULAR AGENT; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIMERCAPROL; EDETIC ACID; FLUMAZENIL; GLUCAGON; GLUCOSE; HEAVY METAL; HYPNOTIC AGENT; LAXATIVE; METHYLENE BLUE; NALOXONE; NEUROLEPTIC AGENT; OCTREOTIDE; PHYSOSTIGMINE; PYRIDOXINE; SEDATIVE AGENT; SORBITOL; THIAMINE; UNINDEXED DRUG; VENOM ANTISERUM;

AGITATION; AIRWAY; ANION GAP; ASPIRATION; BEHAVIOR; BRADYCARDIA; BREATHING; BRONCHOSPASM; CELL HYPOXIA; CIRCULATION; CLINICAL FEATURE; CONFUSION; DELIRIUM; DEPRESSION; DIURESIS; DRUG ABUSE; DYSKINESIA; DYSTONIA; ENDOTRACHEAL INTUBATION; GRAND MAL SEIZURE; HEMODIALYSIS; HEMOFILTRATION; HEMOPERFUSION; HUMAN; HYPERTHERMIA; HYPOTHERMIA; HYPOVENTILATION; HYPOXEMIA; INTENSIVE CARE; INTOXICATION; LABORATORY TEST; LUNG EDEMA; LUNG HEMORRHAGE; MENTAL HEALTH; METABOLIC ACIDOSIS; MIOSIS; MUSCLE TONE; MYDRIASIS; PHYSICAL EXAMINATION; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; RIGIDITY; STOMACH EMPTYING; TACHYCARDIA; UNITED STATES; URINE PH; VOMITING;

EID: 0037331543     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.2.577     Document Type: Review

References (84)

1. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 2001; 19:337-395
2. Wright N. An assessment of the unreliability of the history given by self-poisoned patients. Clin Toxicol 1980; 16:381-384
3. Olson KR, Pentel PR, Kelley MT. Physical assessment and differential diagnosis of the poisoned patient. Med Toxicol 1987; 2:52-81
4. Winter SD, Pearson R, Gabow PA, et al. The fall of the serum anion gap. Arch Intern Med 1990; 150:311-313
5. Gabow PA. Disorders associated with an altered anion gap. Kidney Int 1985; 27:472-483
6. Ammar KA, Heckerling PS. Ethylene glycol poisoning with a normal anion gap caused by concurrent ethanol ingestion: importance of the osmolal gap. Am J Kidney Dis 1996; 27:130-133
7. Walker JA, Schwartzbard A, Krauss EA, et al. The missing gap: a pitfall in the diagnosis of alcohol intoxication by osmometry. Arch Intern Med 1986; 146:1843-1844
8. Sweeney TE, Beuchat CA. Limitations of methods of osmometry: measuring the osmolality of biological fluids. Am J Physiol 1993; 264:R469-R480
9. Glasser L, Sternglanz PD, Combie J, et al. Serum osmolality and its applicability to drug overdose. Am J Clin Pathol 1973; 60:695-699
10. Glaser DS. Utility of the serum osmolal gap in the diagnosis of methanol or ethylene glycol ingestion. Ann Emerg Med 1996; 27:343-346
11. Trummel J, Ford M, Autin P. Ingestion of an unknown alcohol. Ann Emerg Med 1996; 27:368-374
12. Hoffman RS, Smilkstein MJ, Howland MA, et al. Osmolal gaps revisited: normal values and limitations. J Toxicol Clin Toxicol 1993; 31:81-93
13. Tremper KK, Barker SJ. Pulse oximetry. Anesthesiology 1989; 70:98-108
14. Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989; 70:112-117
15. LeGrand TS, Peters JI. Pulse oximetry: advantages and pitfalls. J Crit Illn 1999; 20:195-206
16. Hampson NB. Pulse oximetry in severe carbon monoxide poisoning. Chest 1998; 114:1036-1041
17. Bozeman WP, Myers RA, Barish RA. Confirmation of the pulse oximetry gap in carbon monoxide poisoning. Ann Emerg Med 1997; 30:608-611
18. Brett AS. Implications of discordance between clinical impression and toxicology analysis in drug overdose. Arch Intern Med 1988; 148:437-441
19. Kellerman AL, Fihn SD, LoGerfo JP, et al. Impact of drug screening in suspected overdose. Ann Emerg Med 1987; 16:1209-1216
20. Mahoney JD, Gross PL, Stern TA, et al. Quantitative serum toxic screening in the management of suspected drug overdose. Am J Emerg Med 1990; 8:16-22
21. Wigder WN, Erickson T, Morse T, et al. Emergency department poison advice telephone calls. Ann Emerg Med 1995; 25:349-352
22. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344:665-671
23. Roy TM, Ossorio MA, Cipolla LM, et al. Pulmonary complications after tricyclic antidepressant overdose. Chest 1989; 96:852-856
24. Aldrich T, Morrsion J, Cesario T. Aspiration after overdosage of sedative or hypnotic drugs. South Med J 1980; 73:456-458
25. Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness: controversies in the use of a "coma cocktail." JAMA 1995; 274:562-569
26. Reuler JB, Girard DE, Cooney TG. Wernicke's encephalopathy. N Engl J Med 1985; 312:1035-1039
27. Goldfrank LR. The several uses of naloxone. Emerg Med 1984; 16:110-116
28. Goldfrank LR, Weisman RS, Errick JK, et al. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med 1986; 15:566-570
29. Ward CF. Pulmonary edema and naloxone [letter]. J Clin Anesth 1996; 8:690
30. Schwartz JA, Koenigsberg MD. Naloxone-induced pulmonary edema. Ann Emerg Med 1987; 16:1294-1296
31. Chiang WK, Goldfrank LR. Substance withdrawal. Emerg Med Clin North Am 1990; 8:616-632
32. Mariani PJ. Seizure associated with low-dose naloxone. Am J Emerg Med 1989; 7:127-129
33. Doyon S, Roberts JR. Reappraisal of the coma cocktail: dextrose, flumazenil, naloxone, and thiamine. Emerg Med Clin North Am 1994; 12:301-316
34. Longmire AW, Seger DL. Topics in clinical pharmacology: flumazenil, a benzodiazepine antagonist. Am J Med Sci 1993; 306:49-52
35. Mordel A, Winkler E, Almog S, et al. Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. Crit Care Med 1992; 20:1733-1734
36. Weinbroum A, Rudick V, Sorkine P, et al. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. Crit Care Med 1996; 24:199-206
37. Barnett R, Grace M, Boothe P, et al. Flumazenil in drug overdose: randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med 1999; 27:78-81
38. Paloucek F. Antidotal flumazenil use: the protamine of the 90s. Crit Care Med 1999; 27:10-11
39. Bond GR, Requa RK, Krenzelok EP, et al. Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann Emerg Med 1993; 22:1403-1407
40. Merigan KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990; 8:479-483
41. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:699-709
42. Shannon M. Ingestion of toxic substances by children. N Engl J Med 2000; 342:186-191
43. Vale JA, Meredith TJ, Proudfoot AT. Syrup of ipecacuanha: is it really useful? BMJ 1986; 293:1321-1322
44. Rudolph JP. Automated gastric lavage and a comparison of 0.9% normal saline solution and tap water irrigant. Ann Emerg Med 1985; 14:1156-1159
45. Thompson AM, Robins JR, Prescott LF, et al. Changes in cardiorespiratory function during gastric lavage for drug overdose. Hum Toxicol 1987; 6:215-218
46. Zimmerman JL. Management issues in toxicology. Semin Respir Crit Care Med 2001; 22:23-28
47. Kulig K, Bar-Or D, Cantrill SV, et al. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14:562-567
48. Comstock EG, Faulkner TP, Boisaubin EV, et al. Studies on the efficacy of gastric lavage as practiced in a large metropolitan hospital. Clin Toxicol 1981; 18:581-597
49. Pond SM, Lewis-Driver DJ, Williams GM, et al. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 1995; 163:345-349
50. Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719
51. Saetta JP, March S, Gaunt ME, et al. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus? J R Soc Med 1991; 84:274-276
52. Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 1982; 307:676-678
53. Varga DW, Roy TM, Ossorio MA. Gastric stapling: a significant risk factor in the treatment of tricyclic antidepressant overdose. J Ky Med Assoc 1989; 87:501-503
54. Givens T, Holloway M, Wason S. Pulmonary aspiration of activated charcoal: a complication of its misuse in overdose management. Pediatr Emerg Care 1992; 8:137-140
55. George DL, McLeod R, Weinstein RA. Contaminated commercial charcoal as a source of fungi in the respiratory tract. Infect Control Hosp Epidemiol 1991; 12:732-734
56. Elliott CG, Colby TV, Kelly TM Charcoal lung: bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674
57. Harris CR, Filandrinos D. Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473
58. Menzies DG, Busuttil A, Prescott LF. Fatal pulmonary aspiration of oral activated charcoal. BMJ 1988; 297:459-460
59. Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:721-741
60. Krenzelok EP, Keller R, Stewart RD. Gastrointestinal transit times of eathartics combined with charcoal. Ann Emerg Med 1985; 14:1152-1155
61. Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med 1990; 19:654-656
62. McNamara RM, Aaron CK, Gembroys M, et al. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose. Ann Emerg Med 1988; 17:243-246
63. Barceloux D, McGuigan M, Hartigan-Go K. Position statement: cathartics. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:743-752
64. Davis GR, Santa Ana CA, Morawski SG, et al. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology 1980; 78:991-995
65. Tenenbein M. Position statement: whole bowel irrigation. American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:753-762
66. Pond SM. Principles of techniques applied to enhance elimination of toxic compounds. In: Goldfrank LR, ed. Goldfrank's toxicologic emergencies. Stamford, CT: Appelton and Lange, 1998; 53-62
67. Krenzelok EP, Leikin JB. Approach to a poisoned patient. Dis Mon 1996; 42:513-608
68. Corbridge TC, Murray P. Toxicology in adults In. Hall J, Schmidt GS, Wood LDH, eds. Principles of critical care. New York, NY: McGraw Hill, 1998; 1473-1525
69. Bradberry SM, Vale JA. Mutiple-dose activated charcoal: a review of relevant clinical studies. J Toxicol Clin Toxicol 1995; 33:407-416
70. Ilkhanipour K, Yealy DM, Krenzelok EP. The comparative efficacy of various multiple-dose activated charcoal regimens. Am J Emerg Med 1992; 10:298-300
71. Vale JA, Krenzelok EP, Barceloux GD, et al. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1999; 37:731-751
72. Cutler RE, Forland SC, St. John Hammond PG, et al. Extracorporeal removal of drugs and poisons by hemodialysis and hemoperfusion. Ann Rev Pharmacol Toxicol 1987; 27:169-191
73. Pond SM. Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 1991; 154:617-622
74. Garella S. Extracorporeal techniques in the treatment of exogenous intoxications. Kidney Int 1988; 33:735-754
75. Rommes JH. Haemoperfusion, indications and side-effects. Arch Toxicol 1992; 15:S40-S49
76. Golper TA, Wedel SK, Kaplan AA, et al. Drug removal by continuous arteriovenous hemofiltration: theory and clinical observations. Int J Artif Organs 1985; 8:307-312
77. Golper TA. Drug removal during continuous renal replacement therapies. Dial Transpl 1993; 22:185-212
78. Bellomo R, Kearly Y, Parkin G, et al. Treatment of life-threatening lithium toxicity with continuous arterio-venous hemodiafiltration. Crit Care Med 1991; 19:836-837
79. Leblanc M, Raymond M, Bonnardeaux A, et al. Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration. Am J Kidney Dis 1996; 27:365-372
80. Menghini VV, Albright RC. Treatment of lithium intoxication with continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 3:E21
81. Brett AS, Rothschild N, Gray R, et al. Predicting the clinical course in intentional drug overdose: implications for the use of the intensive care unit. Arch Intern Med 1987; 147:133-137
82. Hamad AE, Al-Ghadban A, Carvounis CP, et al. Predicting the need for medical intensive care monitoring in drug-overdosed patients. J Intensive Care Med 2000; 15:321-328
83. Kulling P, Persson H. The role of the intensive care unit in the management of the poisoned patient. Med Toxicol 1986; 1:375-386
84. Callaham M. Admission criteria for tricyclic antidepressant ingestion. West J Med 1982; 137:425-429